Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds

Information

  • Research Project
  • 10288039
  • ApplicationId
    10288039
  • Core Project Number
    R21ES033323
  • Full Project Number
    1R21ES033323-01
  • Serial Number
    033323
  • FOA Number
    PA-20-195
  • Sub Project Id
  • Project Start Date
    8/1/2021 - 3 years ago
  • Project End Date
    7/31/2023 - a year ago
  • Program Officer Name
    SCHUG, THADDEUS
  • Budget Start Date
    8/1/2021 - 3 years ago
  • Budget End Date
    7/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    7/30/2021 - 3 years ago

Cardiovascular Benefits of Inhaled Biogenic Volatile Organic Compounds

Program Director/Principal Investigator (Last, First, Middle): Conklin, Daniel J., Ph.D. ABSTRACT Extensive epidemiological evidence suggests that exposure to vegetation and residential proximity to greenspaces lowers the risk of all-cause mortality, cardiovascular disease, anxiety, depression and aggression. Although it has been suggested that urban greenspaces exert their beneficial effects by removing air pollutants and promoting physical activity, plants emit biogenic volatile organic chemicals (BVOCs), which by eliciting beneficial cardiovascular and neurological effects could mediate the salutary effects of vegetation. Vegetation is a major underappreciated domain of the natural environment that has received limited interest. Exposure to greenspace within the natural environment has been linked to improvements in cardiovascular health. We propose that plant-derived BVOCs including pinenes, limonene, and citronellol stimulate distinct signaling pathways, in part, by activating the transient receptor potential ankyrin-1 (TRPA1) channel on cardiovascular targets. In endothelial cells, for example, activation of TRPA1 releases nitric oxide that lowers blood pressure, improves cardiovascular function and tamps down inflammation and thrombosis leading to an overall decrease in cardiovascular disease risk. Completion of this project will rigorously establish beneficial cardiovascular effects of inhaled BVOCs that are prevalent in human environments. Moreover, our studies will provide a first test of hypothesis that beneficial effects of inhaled BVOCs are mediated, in part, by TRPA1. These preclinical studies may also lead to the development of biomarkers of exposure to greenness, which likely will be useful in clinical evaluation of the potential therapeutic use of greenness (e.g., planting trees) to decrease CVD risk in human populations. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page

IC Name
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
  • Activity
    R21
  • Administering IC
    ES
  • Application Type
    1
  • Direct Cost Amount
    150000
  • Indirect Cost Amount
    84063
  • Total Cost
    234063
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    113
  • Ed Inst. Type
    SCHOOLS OF PUBLIC HEALTH
  • Funding ICs
    NIEHS:234063\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    SIEE
  • Study Section Name
    Systemic Injury by Environmental Exposure
  • Organization Name
    UNIVERSITY OF LOUISVILLE
  • Organization Department
    PUBLIC HEALTH & PREV MEDICINE
  • Organization DUNS
    057588857
  • Organization City
    LOUISVILLE
  • Organization State
    KY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    402920001
  • Organization District
    UNITED STATES